Drug intelligence / Profile preview

RG-1970

Development stage
Unknown
Lead developer
Hangzhou Ronggu Biotechnology
Modality
CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

RG-1970 is a dual-targeted chimeric antigen receptor natural killer (CAR-NK) cell therapy developed by Hangzhou RonGu Biotechnology, in collaboration with Belief BioMed and Innovent Biologics. It is designed using a lentiviral vector and a nanobody-based CAR structure to simultaneously target CD19 and CD70 on malignant cells, mediating cytotoxic killing. RG-1970 is being developed for the treatment of B-cell non-Hodgkin lymphoma (B-NHL), with investigator-initiated trials (IIT) ongoing since the second quarter of 2023.

Other names
CD19/CD70 CAR-NK cells therapyCD19/CD70 CAR-NK therapy
02

Targets

CD27 (Cluster of Differentiation 27)CD70 (Cluster of Differentiation 70)CD19 (B lymphocyte antigen CD19)

Beyond the preview

Go deeper on RG-1970.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RG-1970.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call